Keywords: guilford, restarts, aquavan, program, pharmaceuticals, usa, says

Guilford restarts Aquavan program

Article | 25 April 2005

Print This

Guilford Pharmaceuticals of the USA says that it can continue clinical development of its lead candidate, Aquavan Injection (GPI 15715), a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in